SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL)
IMCL 0.1590.0%Oct 5 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (1878)1/24/2002 5:43:44 AM
From: Arthur Radley  Read Replies (1) of 2515
 
As for your question about management selling on the open market, in all candor I wasn't aware of that this was going on to any great degree. I did note that a former executive was selling his shares....again he is a former executive. If what you indicate is true, I assume that it took place in 2001 and it might have been done for several reasons, even I sell stock for various reasons...taxes, tuition, etc. And in the case of the proposed secondary offering, that is it....proposed offering and maybe the person or persons that you allude couldn't wait until the "proposed" offering actually takes place.

Thanks for bringing this issue to my attention. However, in my opinion selling stock by a company executive in an open fashion doesn't equate to a company executive blatantly lying to the public about the drug that his company is working on as in the case of IMCL. If BTRN management is engaged in borderline criminal activity as IMCL's CEO, I would appreciate you bringing this to my attention, also.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext